Cancer cytopathology

Keyphrases

Publications

volume 132, number 4, 2024

Bryn Nelson, William Faquin
Growing cancer risks on a warming planet: In this first of a two-part series on cancer and climate change, recent natural disasters highlight how global warming is increasing cancer risks and widening health disparities. Cancer cytopathology 132 (4) (2024)
Kosuke Miyai, Misaki Nakayama, Shinya Minabe, Sho Ogata, Keiichi Ito, Susumu Matsukuma
Implementation of The Paris System for Reporting Urine Cytology improves diagnostic accuracy of selective upper urinary tract cytology. Cancer cytopathology 132 (4) (2024)
Irena Srebotnik Kirbis, Ivana Kholová, Heini Huhtala, Massimo Bongiovanni, Margareta Strojan Flezar, Chantell Hodgson, Beatrix Cochand-Priollet
Cell block practices in European cytopathology laboratories. Cancer cytopathology 132 (4) (2024)
Kosuke Miyai, Misaki Nakayama, Shinya Minabe, Sho Ogata, Keiichi Ito, Susumu Matsukuma
Implementation of The Paris System for Reporting Urine Cytology improves diagnostic accuracy of selective upper urinary tract cytology. Cancer cytopathology 132 (4) (2024)
Alexandra M Miller, Tejus A Bale
Leveraging archival cerebrospinal fluid samples for genetic insights from cell-free DNA. Cancer cytopathology 132 (4) (2024)
Stephan E P Kops, Lizanne J W van der Burgt, Shoko Vos, Lia J M van Zuijlen-Manders, Roel L J Verhoeven, Erik H F M van der Heijden
Rapid on-site evaluation of touch imprint cytology in navigation bronchoscopy for small peripheral pulmonary nodules. Cancer cytopathology 132 (4) (2024)
Alexandra M Miller, Tejus A Bale
Leveraging archival cerebrospinal fluid samples for genetic insights from cell-free DNA. Cancer cytopathology 132 (4) (2024)
Stephan E P Kops, Lizanne J W van der Burgt, Shoko Vos, Lia J M van Zuijlen-Manders, Roel L J Verhoeven, Erik H F M van der Heijden
Rapid on-site evaluation of touch imprint cytology in navigation bronchoscopy for small peripheral pulmonary nodules. Cancer cytopathology 132 (4) (2024)
Michiya Nishino
Cytologic risk stratification of medullary thyroid carcinoma: Does it make the grade? Cancer cytopathology 132 (4) (2024)

volume 132, number 5, 2024

Samantha Peiling Yang, Min En Nga, Manish Mahadeorao Bundele, Simion I Chiosea, Sze Hwa Tan, Jeffrey H Y Lum, Rajeev Parameswaran, Ming Yann Lim, Hao Li, Wei Keat Cheah, Kathleen Su-Yen Sek, Andre Teck Huat Tan, Thomas Kwok Seng Loh, Kee Yuan Ngiam, Wee Boon Tan, Xinyong Huang, Thomas Wai Thong Ho, Keng Hua Lim, Chwee Ming Lim, Reyaz M Singaporewalla, Anil Dinkar Rao, Nandini C L Rao, Dennis Yu Kim Chua, David Chao-Wu Chin, Abigail I Wald, Virginia A LiVolsi, Yuri E Nikiforov, E Shyong Tai
Performance of a multigene genomic classifier and clinical parameters in predicting malignancy in a Southeast Asian cohort of patients with cytologically indeterminate thyroid nodules. Cancer cytopathology 132 (5) (2024)
Hugo Rimbach, Jan Philipp Kühn, Sandrina Körner, Sigrun Smola, Barbara Linxweiler, Stefanie Speicher, Johanna Helfrich, Erich-Franz Solomayer, Mathias Wagner, Bernhard Schick, Jan Philipp Kühn
Prediction of lymph node status in patients with surgically treated head and neck squamous cell carcinoma via neck lavage cytology: A pilot study. Cancer cytopathology 132 (5) (2024)
Olawunmi Folarin, David Kim, Hamza Numan Gokozan, Jonas J Heymann, Jose V Scarpa Carniello, Lucelina Rosado, Momin T Siddiqui, Ami Patel
Interobserver agreement and risk of malignancy using the International Academy of Cytology Yokohama System for reporting breast FNA biopsy in a liquid-based exclusive cohort. Cancer cytopathology 132 (5) (2024)
Yara Mansour, Mehdi Boubaddi, Typhaine Odion, Marion Marty, Geneviève Belleannée, Arthur Berger, Clément Subtil, Christophe Laurent, Sandrine Dabernat, Samuel Amintas
Droplet digital polymerase chain reaction detection of KRAS mutations in pancreatic FNA samples: Technical and practical aspects for routine clinical implementation. Cancer cytopathology 132 (5) (2024)
Bryn Nelson, William Faquin
Climate change is threatening access to cancer care: In this second of a two-part series on cancer and climate change, natural disasters fueled by global warming are creating new obstacles to cancer care for vulnerable communities. Cancer cytopathology 132 (5) (2024)
Olawunmi Folarin, David Kim, Hamza Numan Gokozan, Jonas J Heymann, Jose V Scarpa Carniello, Lucelina Rosado, Momin T Siddiqui, Ami Patel
Interobserver agreement and risk of malignancy using the International Academy of Cytology Yokohama System for reporting breast FNA biopsy in a liquid-based exclusive cohort. Cancer cytopathology 132 (5) (2024)
Samantha Peiling Yang, Min En Nga, Manish Mahadeorao Bundele, Simion I Chiosea, Sze Hwa Tan, Jeffrey H Y Lum, Rajeev Parameswaran, Ming Yann Lim, Hao Li, Wei Keat Cheah, Kathleen Su-Yen Sek, Andre Teck Huat Tan, Thomas Kwok Seng Loh, Kee Yuan Ngiam, Wee Boon Tan, Xinyong Huang, Thomas Wai Thong Ho, Keng Hua Lim, Chwee Ming Lim, Reyaz M Singaporewalla, Anil Dinkar Rao, Nandini C L Rao, Dennis Yu Kim Chua, David Chao-Wu Chin, Abigail I Wald, Virginia A LiVolsi, Yuri E Nikiforov, E Shyong Tai
Performance of a multigene genomic classifier and clinical parameters in predicting malignancy in a Southeast Asian cohort of patients with cytologically indeterminate thyroid nodules. Cancer cytopathology 132 (5) (2024)
Hugo Rimbach, Jan Philipp Kühn, Sandrina Körner, Sigrun Smola, Barbara Linxweiler, Stefanie Speicher, Johanna Helfrich, Erich-Franz Solomayer, Mathias Wagner, Bernhard Schick, Jan Philipp Kühn
Prediction of lymph node status in patients with surgically treated head and neck squamous cell carcinoma via neck lavage cytology: A pilot study. Cancer cytopathology 132 (5) (2024)
Diane M Libert, Yili Zhu, Aihui Wang, Grace M Allard, Alarice Cheng-Yi Lowe
Detection of effusion tumor cells under different storage and processing conditions. Cancer cytopathology 132 (5) (2024)
Yara Mansour, Mehdi Boubaddi, Typhaine Odion, Marion Marty, Geneviève Belleannée, Arthur Berger, Clément Subtil, Christophe Laurent, Sandrine Dabernat, Samuel Amintas
Droplet digital polymerase chain reaction detection of KRAS mutations in pancreatic FNA samples: Technical and practical aspects for routine clinical implementation. Cancer cytopathology 132 (5) (2024)

volume 132, number 6, 2024

Tikamporn Jitpasutham, Stefen Andrianus, Maria Gubbiotti, Vania Nosé, Zubair W Baloch, Emilio Madrigal, William C Faquin Md PhD
Thyroid nodules with DICER1 mutation or PTEN alteration: A comparative cytologic, clinical, and molecular study of 117 FNA cases. Cancer cytopathology 132 (6) (2024)
Jaylou M Velez Torres
Spotlight: Rising stars in cytology. Cancer cytopathology 132 (6) (2024)
Tikamporn Jitpasutham, Stefen Andrianus, Maria Gubbiotti, Vania Nosé, Zubair W Baloch, Emilio Madrigal, William C Faquin Md PhD
Thyroid nodules with DICER1 mutation or PTEN alteration: A comparative cytologic, clinical, and molecular study of 117 FNA cases. Cancer cytopathology 132 (6) (2024)
Krisztina Lengyel, Daniel J Lubin, Wen-Yu Hsiao, Sam Sirotnikov, Guangju Luo, James W Roberts, Qiuying Shi, Kelly Magliocca, Melinda M Lewis, Donald L Sears, Ghulam Ilyas, Beverly B Rogers, Kartik Viswanathan
Comprehensive evaluation of cytomorphologic, histologic, and molecular features of DICER1-altered thyroid lesions on FNA: A multipractice experience. Cancer cytopathology 132 (6) (2024)
Tarik M Elsheikh, Matthew Thomas, Jennifer Brainard, Jessica Di Marco, Erica Manosky, Bridgette Springer, Dawn Underwood, Deborah J Chute
Papillae, psammoma bodies, and/or many nuclear pseudoinclusions are helpful criteria but should not be required for a definitive cytologic diagnosis of papillary thyroid carcinoma: An institutional experience of 207 cases with surgical follow up. Cancer cytopathology 132 (6) (2024)
Jaylou M Velez Torres
Spotlight: Rising stars in cytology. Cancer cytopathology 132 (6) (2024)
Krisztina Lengyel, Daniel J Lubin, Wen-Yu Hsiao, Sam Sirotnikov, Guangju Luo, James W Roberts, Qiuying Shi, Kelly Magliocca, Melinda M Lewis, Donald L Sears, Ghulam Ilyas, Beverly B Rogers, Kartik Viswanathan
Comprehensive evaluation of cytomorphologic, histologic, and molecular features of DICER1-altered thyroid lesions on FNA: A multipractice experience. Cancer cytopathology 132 (6) (2024)
Lei Ye, Meifu Gan, Yeli Yao, Bingjian Lu
Retrospective analysis of cytology and high-risk HPV testing in 1067 endocervical adenocarcinomas and precursor lesions. Cancer cytopathology 132 (6) (2024)
Bryn Nelson, William Faquin
Reimagining the future of cancer clinical trials: Reformers are eyeing multiple ways to make drug trials more efficient, patient-centered, and likely to succeed. Cancer cytopathology 132 (6) (2024)
Krisztina Lengyel, Daniel J Lubin, Wen-Yu Hsiao, Sam Sirotnikov, Guangju Luo, James W Roberts, Qiuying Shi, Kelly Magliocca, Melinda M Lewis, Donald L Sears, Ghulam Ilyas, Beverly B Rogers, Kartik Viswanathan
Comprehensive evaluation of cytomorphologic, histologic, and molecular features of DICER1-altered thyroid lesions on FNA: A multipractice experience. Cancer cytopathology 132 (6) (2024)
Bryn Nelson, William Faquin
Reimagining the future of cancer clinical trials: Reformers are eyeing multiple ways to make drug trials more efficient, patient-centered, and likely to succeed. Cancer cytopathology 132 (6) (2024)

volume 132, number 7, 2024

Marc Philippe Pusztaszeri
Is molecular testing of salivary gland FNA specimens ready for prime time? Cancer cytopathology 132 (7) (2024)
Sandra N Freiberger, Kristian Ikenberg, Demi van Egmond, Sofie Claerhout, Tom van Wezel, Isabelle Vanden Bempt, Jeroen N van Rossem, Simon A Mueller, Paul M Clement, Vincent Vander Poorten, Danielle Cohen, Esther Hauben, Niels J Rupp
Molecular analysis using SalvGlandDx improves risk of malignancy estimation and diagnosis of salivary gland cytopathology: An exploratory multicenter study. Cancer cytopathology 132 (7) (2024)
Henri Lagerstam, David Kalfert, Zahra Maleki, Ivana Kholová
How the Milan System for Reporting Salivary Gland Cytopathology works in cytopathology practice: Meta-analysis of prospective studies and comparison with retrospective studies. Cancer cytopathology 132 (7) (2024)
Maria Benevolo, Francesca Rollo, Alessandra Latini, Massimo Giuliani, Amalia Giglio, Eugenia Giuliani, Maria Gabriella Donà
Interobserver agreement in the interpretation of anal cytology. Cancer cytopathology 132 (7) (2024)
Bryn Nelson, William Faquin
The power and pitfalls of using social media to study rare cancers: Facebook, X, and other platforms can aid patient education and recruitment efforts, though experts caution that studies can be methodologically limited and unrepresentative. Cancer cytopathology 132 (7) (2024)
Xi Wang, Xuchen Zhang, Pei Hui, Guoping Cai
Improving diagnostic yield of pancreatic serous cystadenoma with cyst fluid ancillary testing, adjunct immunohistochemistry, and additional fine-needle biopsy sampling. Cancer cytopathology 132 (7) (2024)
Barbara A Centeno, Mauro Ajaj Saieg, Momin T Siddiqui, Miguel A Perez-Machado, Lester J Layfield, Birgit Weynand, Michelle D Reid, Edward B Stelow, María Dolores Lozano, Noriyoshi Fukushima, Ian A Cree, Ravi Mehrotra, Fernando C Schmitt, Andrew S Field, Martha B Pitman
The World Health Organization Reporting System for Pancreaticobiliary Cytopathology: Overview and Summary. Cancer cytopathology 132 (7) (2024)

volume 132, number 8, 2024

Marc Philippe Pusztaszeri, Mauro Ajaj Saieg, Zubair W Baloch
Risks of malignancy in the major nongynecologic cytopathology reporting systems: Critiques and discussions. Cancer cytopathology 132 (8) (2024)
Odille Mejia-Mejia, Andres Bravo-Gonzalez, Monica Sanchez-Avila, Youley Tjendra, Rodrigo Santoscoy, Katherine Drews-Elger, Yiqin Zuo, Camilo Arias-Abad, Carmen Gomez, Monica Garcia-Buitrago, Mehrdad Nadji, Merce Jorda, Jaylou M Velez Torres, Roberto Ruiz-Cordero
Atypia of undetermined significance and ThyroSeq v3-positive call rates as quality control metrics for cytology laboratory performance. Cancer cytopathology 132 (8) (2024)
Vanda F Torous, Tikamporn Jitpasutham, Zubair Baloch, Richard L Cantley, Darcy A Kerr, Xiaoying Liu, Zahra Maleki, Ross Merkin, Vania Nosé, Liron Pantanowitz, Isabella Tondi Resta, Esther Diana Rossi, William C Faquin Md PhD
Cytologic features of differentiated high-grade thyroid carcinoma: A multi-institutional study of 40 cases. Cancer cytopathology 132 (8) (2024)
Kübra Katipoglu, Irem Kilic, Olcay Kurtulan, Yasemin Akdas, Güliz A Barkan
A systematic review on performance characteristics of FNA of renal lesions: It is time for a standardized classification system. Cancer cytopathology 132 (8) (2024)
Vanda F Torous, Tikamporn Jitpasutham, Zubair Baloch, Richard L Cantley, Darcy A Kerr, Xiaoying Liu, Zahra Maleki, Ross Merkin, Vania Nosé, Liron Pantanowitz, Isabella Tondi Resta, Esther Diana Rossi, William C Faquin Md PhD
Cytologic features of differentiated high-grade thyroid carcinoma: A multi-institutional study of 40 cases. Cancer cytopathology 132 (8) (2024)
Jaylou M Velez Torres, Porshya M Curnow, Youley Tjendra, Merce Jorda, Carmen Gomez Fernandez, Monica Garcia Buitrago, Yiqin Zuo, Roberto Ruiz Cordero
Exploring the atypia of undetermined significance: Malignant ratio, ThyroSeq v3 positive call rate, molecular-derived risk of malignancy, and risk of malignancy as possible quality metric tools in thyroid cytology. Cancer cytopathology 132 (8) (2024)
Jaylou M Velez Torres, Porshya M Curnow, Youley Tjendra, Merce Jorda, Carmen Gomez Fernandez, Monica Garcia Buitrago, Yiqin Zuo, Roberto Ruiz Cordero
Exploring the atypia of undetermined significance: Malignant ratio, ThyroSeq v3 positive call rate, molecular-derived risk of malignancy, and risk of malignancy as possible quality metric tools in thyroid cytology. Cancer cytopathology 132 (8) (2024)
Odille Mejia-Mejia, Andres Bravo-Gonzalez, Monica Sanchez-Avila, Youley Tjendra, Rodrigo Santoscoy, Katherine Drews-Elger, Yiqin Zuo, Camilo Arias-Abad, Carmen Gomez, Monica Garcia-Buitrago, Mehrdad Nadji, Merce Jorda, Jaylou M Velez Torres, Roberto Ruiz-Cordero
Atypia of undetermined significance and ThyroSeq v3-positive call rates as quality control metrics for cytology laboratory performance. Cancer cytopathology 132 (8) (2024)
Bryn Nelson, William Faquin
Exposing the naked truth about how mole-rats evade cancer: In this first of a two-part series on what we can learn from unusually cancer-resistant or -susceptible animals, researchers are exploring how adaptations to their extreme environment may have given naked mole-rats potent cancer-fighting tools. Cancer cytopathology 132 (8) (2024)
Kübra Katipoglu, Irem Kilic, Olcay Kurtulan, Yasemin Akdas, Güliz A Barkan
A systematic review on performance characteristics of FNA of renal lesions: It is time for a standardized classification system. Cancer cytopathology 132 (8) (2024)
Linh Ho, Tarik M Elsheikh
Atypical squamous cells in urine cytology are associated with a significant risk of high-grade malignancy. Cancer cytopathology 132 (8) (2024)
Linh Ho, Tarik M Elsheikh
Atypical squamous cells in urine cytology are associated with a significant risk of high-grade malignancy. Cancer cytopathology 132 (8) (2024)
Marc Philippe Pusztaszeri, Mauro Ajaj Saieg, Zubair W Baloch
Risks of malignancy in the major nongynecologic cytopathology reporting systems: Critiques and discussions. Cancer cytopathology 132 (8) (2024)